Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India.
Pankaj BahugunaShankar PrinjaChandrakant LahariyaRadha Krishan DhimanMadhumita Prem KumarVineeta SharmaArun Kumar AggarwalRajesh BhaskarHilde De GraeveHenk BekedamPublished in: Applied health economics and health policy (2021)
RUP syringes are estimated to be cost-effective in the Indian context. SIP and RUP + SIP syringes are not cost-effective at the current unit prices. Efforts should be made to bring down the price of SES to improve its cost-effectiveness.